A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320 (Q37087347)
Jump to navigation
Jump to search
scientific article published on 04 February 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320 |
scientific article published on 04 February 2013 |
Statements
1 reference
A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320 (English)
1 reference
Maria Werner-Wasik
1 reference
Ritsuko Komaki
1 reference
Paul W Sperduto
1 reference
Meihua Wang
1 reference
H Ian Robins
1 reference
Michael C Schell
1 reference
Luis Souhami
1 reference
Mark K Buyyounouski
1 reference
Deepak Khuntia
1 reference
William Demas
1 reference
Sunjay A Shah
1 reference
Lucien A Nedzi
1 reference
Gad Perry
1 reference
John H Suh
1 reference
4 February 2013
1 reference
1 reference
1312-1318
1 reference
Identifiers
1 reference
1 reference
1 reference